Artykuły w czasopismach na temat „Drug screenings”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Drug screenings”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
O’Neil, Meghan M. "Drug Screenings in Practice". Federal Sentencing Reporter 36, nr 4 (1.04.2024): 212–17. http://dx.doi.org/10.1525/fsr.2024.36.4.212.
Pełny tekst źródłaLiang, Qiying, Peng Ma, Qi Zhang, Youjie Yin, Ping Wang, Saifei Wang, Yao Zhang, Ruolei Han i Hansong Deng. "A gum Arabic assisted sustainable drug delivery system for adult Drosophila". Biology Open 9, nr 6 (2.06.2020): bio052241. http://dx.doi.org/10.1242/bio.052241.
Pełny tekst źródłaPopova, Anna A., Claire Depew, Katya Manuella Permana, Alexander Trubitsyn, Ravindra Peravali, Jorge Ángel González Ordiano, Markus Reischl i Pavel A. Levkin. "Evaluation of the Droplet-Microarray Platform for High-Throughput Screening of Suspension Cells". SLAS TECHNOLOGY: Translating Life Sciences Innovation 22, nr 2 (15.11.2016): 163–75. http://dx.doi.org/10.1177/2211068216677204.
Pełny tekst źródłaVacchina, Paola, i Miguel A. Morales. "In VitroScreening Test Using Leishmania Promastigotes Stably Expressing mCherry Protein". Antimicrobial Agents and Chemotherapy 58, nr 3 (6.01.2014): 1825–28. http://dx.doi.org/10.1128/aac.02224-13.
Pełny tekst źródłaHann, Christina. "Random Drug Screenings: Nothing to Lose?" American Pharmacy 27, nr 10 (październik 1987): 34–36. http://dx.doi.org/10.1016/s0160-3450(16)33340-2.
Pełny tekst źródłaWilliams, Petal Petersen, Catherine Mathews, Esmé Jordaan, Yukiko Washio, Mishka Terplan i Charles DH Parry. "Validation of simple dichotomous self-report on prenatal alcohol and other drug use in women attending midwife obstetric units in the Cape Metropole, South Africa". Clinical Ethics 15, nr 4 (31.05.2020): 181–86. http://dx.doi.org/10.1177/1477750920928885.
Pełny tekst źródłaNguemeni Tiako, Max Jordan, Abby Dolan, Matthew Abrams, Kehinde Oyekanmi, Zachary Meisel i Shoshana V. Aronowitz. "Thematic Analysis of State Medicaid Buprenorphine Prior Authorization Requirements". JAMA Network Open 6, nr 6 (15.06.2023): e2318487. http://dx.doi.org/10.1001/jamanetworkopen.2023.18487.
Pełny tekst źródłaSalas-Sarduy, Emir, Gabriela T. Niemirowicz, Juan José Cazzulo i Vanina E. Alvarez. "Target-based Screening of the Chagas Box: Setting Up Enzymatic Assays to Discover Specific Inhibitors Across Bioactive Compounds". Current Medicinal Chemistry 26, nr 36 (13.12.2019): 6672–86. http://dx.doi.org/10.2174/0929867326666190705160637.
Pełny tekst źródłaDegliesposti, Gianluca, Corinne Portioli, Marco Daniele Parenti i Giulio Rastelli. "BEAR, a Novel Virtual Screening Methodology for Drug Discovery". Journal of Biomolecular Screening 16, nr 1 (17.11.2010): 129–33. http://dx.doi.org/10.1177/1087057110388276.
Pełny tekst źródłaBintener, Tamara, Maria Pires Pacheco i Thomas Sauter. "Towards the routine use of in silico screenings for drug discovery using metabolic modelling". Biochemical Society Transactions 48, nr 3 (5.05.2020): 955–69. http://dx.doi.org/10.1042/bst20190867.
Pełny tekst źródłaFischer, Matthias, Stefan Unterecker i Jürgen Deckert. "False-Positive Phencyclidine Drug Screenings During Psychopharmacologic Treatment". Journal of Clinical Psychiatry 75, nr 07 (15.07.2014): 728–30. http://dx.doi.org/10.4088/jcp.13cr08955.
Pełny tekst źródłaMoya, Elisa L. J., Elodie Vandenhaute, Eleonora Rizzi, Marie-Christine Boucau, Johan Hachani, Nathalie Maubon, Fabien Gosselet i Marie-Pierre Dehouck. "Miniaturization and Automation of a Human In Vitro Blood–Brain Barrier Model for the High-Throughput Screening of Compounds in the Early Stage of Drug Discovery". Pharmaceutics 13, nr 6 (16.06.2021): 892. http://dx.doi.org/10.3390/pharmaceutics13060892.
Pełny tekst źródłaCai, Linda, Annina Kemmer, Niels Krausch, Peter Neubauer i M. Nicolas Cruz Bournazou. "Hochdurchsatz-Strategien für modellbasierte Bioprozessentwicklung". BIOspektrum 30, nr 2 (marzec 2024): 177–79. http://dx.doi.org/10.1007/s12268-024-2142-9.
Pełny tekst źródłaIannaccone, Teresa, Carmine Sellitto, Valentina Manzo, Francesca Colucci, Valentina Giudice, Berenice Stefanelli, Antonio Iuliano, Giulio Corrivetti i Amelia Filippelli. "Pharmacogenetics of Carbamazepine and Valproate: Focus on Polymorphisms of Drug Metabolizing Enzymes and Transporters". Pharmaceuticals 14, nr 3 (1.03.2021): 204. http://dx.doi.org/10.3390/ph14030204.
Pełny tekst źródłaGallinger, Tom L., Samuel Y. Aboagye, Wiebke Obermann, Michael Weiss, Arnold Grünweller, Carlo Unverzagt, David L. Williams, Martin Schlitzer i Simone Haeberlein. "First In Silico Screening of Insect Molecules for Identification of Novel Anti-Parasitic Compounds". Pharmaceuticals 15, nr 2 (19.01.2022): 119. http://dx.doi.org/10.3390/ph15020119.
Pełny tekst źródłaRosa, João Gabriel Santos, Carla Lima i Monica Lopes-Ferreira. "Zebrafish Larvae Behavior Models as a Tool for Drug Screenings and Pre-Clinical Trials: A Review". International Journal of Molecular Sciences 23, nr 12 (14.06.2022): 6647. http://dx.doi.org/10.3390/ijms23126647.
Pełny tekst źródłaSugimoto, Keiki, Fumihiko Hayakawa, Takahiko Yasuda i Tomoki Naoe. "Drug Development Targeting Microenvironment for Malignant Lymphoma". Blood 120, nr 21 (16.11.2012): 1661. http://dx.doi.org/10.1182/blood.v120.21.1661.1661.
Pełny tekst źródłaBellomo, Francesco, Ester De Leo, Anna Taranta, Laura Giaquinto, Gianna Di Giovamberardino, Sandro Montefusco, Laura Rita Rega i in. "Drug Repurposing in Rare Diseases: An Integrative Study of Drug Screening and Transcriptomic Analysis in Nephropathic Cystinosis". International Journal of Molecular Sciences 22, nr 23 (27.11.2021): 12829. http://dx.doi.org/10.3390/ijms222312829.
Pełny tekst źródłaFielmich, Lars-Eric, Annemarie Buijs, Daniele Mori, Bas Viergever, Nihed Draoui, Anna Schepers, Mariana M. Costa e Silva i in. "Abstract 189: Developing a patient-derived organoid biobank, suitable for large scale drug screenings". Cancer Research 83, nr 7_Supplement (4.04.2023): 189. http://dx.doi.org/10.1158/1538-7445.am2023-189.
Pełny tekst źródłaHagan, Daniel, i Martin Hagan. "Soft Computing Tools for Virtual Drug Discovery". Journal of Artificial Intelligence and Soft Computing Research 8, nr 3 (1.07.2018): 173–89. http://dx.doi.org/10.1515/jaiscr-2018-0012.
Pełny tekst źródłaFischer, M., S. Unterecker i J. Deckert. "EPA-1097 - False positive phencyclidine drug screenings during psychopharmacologic treatment". European Psychiatry 29 (2014): 1. http://dx.doi.org/10.1016/s0924-9338(14)78374-9.
Pełny tekst źródłaButterweck, Veronika, Hartmut Derendorf, Wilhelm Gaus, Adolf Nahrstedt, Volker Schulz i Matthias Unger. "Pharmacokinetic Herb-Drug Interactions: Are Preventive Screenings Necessary and Appropriate?" Planta Medica 70, nr 9 (wrzesień 2004): 784–91. http://dx.doi.org/10.1055/s-2004-827223.
Pełny tekst źródłaKim, Jungeun, Hoe Suk Kim, Ga Yeon Kim, Kyung hyeun Park, Seung yeon Ryu, Sangeun Lee, Dong Woo Lee, Bosung Ku, Han-Byoel Lee i Wonshik Han. "Abstract P5-02-02: Development of automated 3D high-throughput drug screening platform for patient-derived breast cancer organoids". Cancer Research 82, nr 4_Supplement (15.02.2022): P5–02–02—P5–02–02. http://dx.doi.org/10.1158/1538-7445.sabcs21-p5-02-02.
Pełny tekst źródłaKojima, Yuki, Fumihiko Hayakawa, Takanobu Morishita, Keiki Sugimoto, Mizuho Iwase, Hideyuki Yamamoto, Daiki Hirano, Naoto Imoto, Seiji Okada i Hitoshi Kiyoi. "YM155 Induces Apoptosis through Proteasome-Dependent Degradation of MCL-1 in Primary Effusion Lymphoma". Blood 128, nr 22 (2.12.2016): 3013. http://dx.doi.org/10.1182/blood.v128.22.3013.3013.
Pełny tekst źródłaDegiacomi, Giulia, Juan Manuel Belardinelli, Maria Rosalia Pasca, Edda De Rossi, Giovanna Riccardi i Laurent Roberto Chiarelli. "Promiscuous Targets for Antitubercular Drug Discovery: The Paradigm of DprE1 and MmpL3". Applied Sciences 10, nr 2 (15.01.2020): 623. http://dx.doi.org/10.3390/app10020623.
Pełny tekst źródłaPorto, Raquel, Ana C. Mengarda, Rayssa A. Cajas, Maria C. Salvadori, Fernanda S. Teixeira, Daniel D. R. Arcanjo, Abolghasem Siyadatpanah, Maria de Lourdes Pereira, Polrat Wilairatana i Josué de Moraes. "Antiparasitic Properties of Cardiovascular Agents against Human Intravascular Parasite Schistosoma mansoni". Pharmaceuticals 14, nr 7 (16.07.2021): 686. http://dx.doi.org/10.3390/ph14070686.
Pełny tekst źródłaPopova, Anna A., Konstantin Demir, Titus Genisius Hartanto, Eric Schmitt i Pavel A. Levkin. "Droplet-microarray on superhydrophobic–superhydrophilic patterns for high-throughput live cell screenings". RSC Advances 6, nr 44 (2016): 38263–76. http://dx.doi.org/10.1039/c6ra06011k.
Pełny tekst źródłaXie, Yujiang, Genpei Shi, Jie Sun, Si Li, Wei Gao, Yimin Hu, Chang Zu, Weiwei Tang i Junbo Gong. "Computational Screening and Experimental Validation on Multicomponent Crystals of a New Class of Janus Kinase (JAK) Inhibitor Drug with Improved Solubility". Crystals 12, nr 12 (27.11.2022): 1722. http://dx.doi.org/10.3390/cryst12121722.
Pełny tekst źródłaSun, Wei, Chwee Teck Lim i Nicholas Agung Kurniawan. "Mechanistic adaptability of cancer cells strongly affects anti-migratory drug efficacy". Journal of The Royal Society Interface 11, nr 99 (6.10.2014): 20140638. http://dx.doi.org/10.1098/rsif.2014.0638.
Pełny tekst źródłaZaveri, Anurag D., Dilip N. Zaveri i Lakshmi Bhaskaran. "Genetyping of Carbapenem-resistant Organisms Isolated from Clinical Isolates Received from Tertiary Care Hospitals of Ahmedabad, Gujarat". Journal of Pure and Applied Microbiology 15, nr 3 (31.08.2021): 1689–96. http://dx.doi.org/10.22207/jpam.15.3.65.
Pełny tekst źródłaMitchell, Ann M., Holly Hagle, Kathy Puskar, Irene Kane, Dawn Lindsay, Kimberly Talcott, Peter F. Luongo i Eric Goplerud. "Alcohol and Other Drug Use Screenings by Nurse Practitioners: Policy Implications". Journal for Nurse Practitioners 11, nr 7 (lipiec 2015): 730–32. http://dx.doi.org/10.1016/j.nurpra.2014.11.025.
Pełny tekst źródłaSanz, Laura M., M. Belen Jiménez-Díaz, Benigno Crespo, Cristina De-Cozar, M. Jesus Almela, Iñigo Angulo-Barturen, Pablo Castañeda i in. "Cyclopropyl Carboxamides, a Chemically Novel Class of Antimalarial Agents Identified in a Phenotypic Screen". Antimicrobial Agents and Chemotherapy 55, nr 12 (3.10.2011): 5740–45. http://dx.doi.org/10.1128/aac.05188-11.
Pełny tekst źródłaNasseri, S. Soroush, Erika M. J. Siren, Jayachandran N. Kizhakkedathu i Karen Cheung. "HyClear: A Novel Tissue Clearing Solution for One-Step Clearing of Microtissues". Cells 11, nr 23 (30.11.2022): 3854. http://dx.doi.org/10.3390/cells11233854.
Pełny tekst źródłaBruch, Eduardo M., Stéphanie Petrella i Marco Bellinzoni. "Structure-Based Drug Design for Tuberculosis: Challenges Still Ahead". Applied Sciences 10, nr 12 (20.06.2020): 4248. http://dx.doi.org/10.3390/app10124248.
Pełny tekst źródłaCheng, Lijun, Abhishek Majumdar, Daniel Stover, Shaofeng Wu, Yaoqin Lu i Lang Li. "Computational Cancer Cell Models to Guide Precision Breast Cancer Medicine". Genes 11, nr 3 (28.02.2020): 263. http://dx.doi.org/10.3390/genes11030263.
Pełny tekst źródłaAbdelkawy, Khaled, Maged Kharouba, Khloud Shendy, Omar Abdelmagged, Naira Galal, Mai Tarek, Mohamed Abdelgaied, Amr Y. Zakaria i Sherif Hanafy Mahmoud. "Prevalence of Drug–Drug Interactions in Primary Care Prescriptions in Egypt: A Cross-Sectional Retrospective Study". Pharmacy 11, nr 3 (18.06.2023): 106. http://dx.doi.org/10.3390/pharmacy11030106.
Pełny tekst źródłaRegenbrecht, Manuela, Rica Sauer, Maya Niethard, Christian RA Regenbrecht i Jürgen Loskutov. "Establishment of PD3D models of sarcomas: A promising preclinical tool for improvement of sarcoma treatment." Journal of Clinical Oncology 40, nr 16_suppl (1.06.2022): e23538-e23538. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.e23538.
Pełny tekst źródłaMahan, Rebecca J., Trista Askins Bailey, Teryn J. Bibb, Megan Fenney i Tara Williams. "Drug Therapy for Gender Transitions and Health Screenings in Transgender Older Adults". Journal of the American Geriatrics Society 64, nr 12 (grudzień 2016): 2554–59. http://dx.doi.org/10.1111/jgs.14350.
Pełny tekst źródłaFerrari, Elisa, Chiara Lucca i Marco Foiani. "A lethal combination for cancer cells: Synthetic lethality screenings for drug discovery". European Journal of Cancer 46, nr 16 (listopad 2010): 2889–95. http://dx.doi.org/10.1016/j.ejca.2010.07.031.
Pełny tekst źródłaJungwirth, Gerhard, Tao Yu, Cao Junguo, Catharina Lotsch, Andreas Unterberg i Christel Herold-Mende. "TMOD-29. STANDARDIZED GENERATION OF TUMOR-ORGANOIDS AS NOVEL DRUG SCREENING MODEL IN MENINGIOMA". Neuro-Oncology 23, Supplement_6 (2.11.2021): vi221—vi222. http://dx.doi.org/10.1093/neuonc/noab196.890.
Pełny tekst źródłaBarbosa, Mélanie A. G., Cristina P. R. Xavier, Rúben F. Pereira, Vilma Petrikaitė i M. Helena Vasconcelos. "3D Cell Culture Models as Recapitulators of the Tumor Microenvironment for the Screening of Anti-Cancer Drugs". Cancers 14, nr 1 (31.12.2021): 190. http://dx.doi.org/10.3390/cancers14010190.
Pełny tekst źródłaDubois, Clémence, Pierre Daumar, Corinne Aubel, Jean Gauthier, Bernard Vidalinc, Emmanuelle Mounetou, Frédérique Penault-Llorca i Mahchid Bamdad. "The New Synthetic Serum-Free Medium OptiPASS Promotes High Proliferation and Drug Efficacy Prediction on Spheroids from MDA-MB-231 and SUM1315 Triple-Negative Breast Cancer Cell Lines". Journal of Clinical Medicine 8, nr 3 (21.03.2019): 397. http://dx.doi.org/10.3390/jcm8030397.
Pełny tekst źródłaBay, Marie L., Aikaterini Skorda, Benita S. Rasmussen, Jaume R. Arias, Anna R. Lauridsen, Kaisa Huhtinen, Sampsa Hautaniemi, Johanna Hynninen i Tuula Kallunki. "Abstract B027: Screening of drug candidates to repurpose for high-grade serous ovarian cancer treatment". Cancer Research 84, nr 5_Supplement_2 (4.03.2024): B027. http://dx.doi.org/10.1158/1538-7445.ovarian23-b027.
Pełny tekst źródłaZietek, Tamara, Wolfgang A. D. Boomgaarden i Eva Rath. "Drug Screening, Oral Bioavailability and Regulatory Aspects: A Need for Human Organoids". Pharmaceutics 13, nr 8 (17.08.2021): 1280. http://dx.doi.org/10.3390/pharmaceutics13081280.
Pełny tekst źródłaTsuji, Motonori. "Virtual Screening and Quantum Chemistry Analysis for SARS-CoV-2 RNA-Dependent RNA Polymerase Using the ChEMBL Database: Reproduction of the Remdesivir-RTP and Favipiravir-RTP Binding Modes Obtained from Cryo-EM Experiments with High Binding Affinity". International Journal of Molecular Sciences 23, nr 19 (20.09.2022): 11009. http://dx.doi.org/10.3390/ijms231911009.
Pełny tekst źródłaOnishi, Iichiroh, Kouhei Yamamoto, Yuko Kinowaki, Masanobu Kitagawa i Morito Kurata. "To Discover the Efficient and Novel Drug Targets in Human Cancers Using CRISPR/Cas Screening and Databases". International Journal of Molecular Sciences 22, nr 22 (15.11.2021): 12322. http://dx.doi.org/10.3390/ijms222212322.
Pełny tekst źródłaIbrahim, Mohammed, Md Aslam Hossain, Md Shafiullah Shajib i Mohammad A. Rashid. "Preliminary Phytochemical and Pharmacological Screenings of Plumbago indica L. and Alpinia conchigera Griff." Dhaka University Journal of Pharmaceutical Sciences 17, nr 1 (24.06.2018): 73–79. http://dx.doi.org/10.3329/dujps.v17i1.37121.
Pełny tekst źródłaBarron, Nadine, Stephan Dickgiesser, Markus Fleischer, Angelika-Nicole Bachmann, Daniel Klewinghaus, Jens Hannewald, Elke Ciesielski i in. "A Generic Approach for Miniaturized Unbiased High-Throughput Screens of Bispecific Antibodies and Biparatopic Antibody–Drug Conjugates". International Journal of Molecular Sciences 25, nr 4 (8.02.2024): 2097. http://dx.doi.org/10.3390/ijms25042097.
Pełny tekst źródłaPudelko, Linda, Steven Edwards, Mirela Balan, Daniel Nyqvist, Jonathan Al-Saadi, Johannes Dittmer, Ingrid Almlöf, Thomas Helleday i Lars Bräutigam. "An orthotopic glioblastoma animal model suitable for high-throughput screenings". Neuro-Oncology 20, nr 11 (10.05.2018): 1475–84. http://dx.doi.org/10.1093/neuonc/noy071.
Pełny tekst źródłaMitchell, Ann M., Holly Hagle, Kathy Puskar, Irene Kane, Dawn Lindsay, Kimberly Talcott, Peter F. Luongo i Eric Goplerud. "Alcohol and Other Drug Use Screenings by Nurse Practitioners: Clinical Issues and Costs". Journal for Nurse Practitioners 11, nr 3 (marzec 2015): 347–51. http://dx.doi.org/10.1016/j.nurpra.2014.12.007.
Pełny tekst źródła